| [February 09, 2016] |
 |
Psoriasis Therapeutics Pipeline Review, H2 2015 - Research and Markets
Research and Markets (http://www.researchandmarkets.com/research/25mfst/psoriasis)
has announced the addition of the "Psoriasis
- Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Multiple Myeloma (Kahler Disease), complete with
comparative analysis at various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press
releases. It also reviews key players involved in the therapeutic
development for Psoriasisand special features on late-stage and
discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
PsoriasisOverview
-
Therapeutics Devlopment
-
Pipeline Products for Psoriasis- Overview
-
Pipeline Products for Psoriasis- Comparative Analysis
-
Psoriasis- Therapeutics under Development by Companies
-
Psoriasis- Therapeutics under Investigation by Universities/Institutes
-
Psoriasis- Pipeline Products Glance
-
Late Stage Products
-
Clinical Stage Products
-
Early Stage Products
-
Psoriasis- Products under Development by Companies
-
Psoriasis- Products under Investigation by Universities/Institutes
-
Psoriasis- Companies Involved in Therapeutics Development
Companies Mentioned - Sample List
-
3SBio Inc.
-
4SC AG
-
Abeome Corporation
-
AbGenomics International, Inc.
-
ADC (News - Alert) Therapeutics Sarl
-
Addex Therapeutics Ltd
-
Advinus Therapeutics Ltd.
-
Ajinomoto Pharmaceuticals Co., Ltd.
-
AlbireoPharma
-
Allozyne, Inc.
-
Almirall, S.A.
-
Amgen Inc.
-
Anacor Pharmaceuticals, Inc.
-
AnaptysBio, Inc.
-
Arena Pharmaceuticals, Inc.
-
Argos Therapeutics, Inc.
-
Arrien Pharmaceuticals, LLC
-
AstraZeneca Plc
-
Athenex, Inc.
-
Aurigene Discovery Technologies Limited
-
Avesthagen Limited
-
Avexxin AS
-
Basilea Pharmaceutica AG
-
BIOCAD
-
Biocon Limited
-
BioLingus AG
-
BioMAS Ltd.
-
Bionomics Limited
-
Bionovis SA
-
Boehringer Ingelheim GmbH
-
Brickell Biotech, Inc.
-
Bristol-Myers Squibb Company
-
Can-Fite BioPharma Ltd.
-
Celgene Corporation
-
Cellceutix Corporation
For more information visit http://www.researchandmarkets.com/research/25mfst/psoriasis
View source version on businesswire.com: http://www.businesswire.com/news/home/20160209006148/en/
[ Back To TMCnet.com's Homepage ]
|
